CURE.DE vs. DAVV.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and DAVV.DE (VanEck Crypto and Blockchain Innovators UCITS ETF) are both exchange-traded funds - CURE.DE is a Health & Biotech Equities fund tracking the MVIS Global Future Healthcare ESG, while DAVV.DE is a Technology Equities fund tracking the MVIS Global Digital Assets Equity. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 52.28%/yr for DAVV.DE. At a 0.43 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.65%/yr for DAVV.DE.
Performance
CURE.DE vs. DAVV.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than DAVV.DE's 27.16% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
DAVV.DE
- 1D
- -3.80%
- 1M
- -0.05%
- YTD
- 27.16%
- 6M
- 13.79%
- 1Y
- 43.77%
- 3Y*
- 52.28%
- 5Y*
- -1.30%
- 10Y*
- —
CURE.DE vs. DAVV.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
DAVV.DE VanEck Crypto and Blockchain Innovators UCITS ETF | 27.16% | -0.68% | 37.42% | 337.08% | -55.13% |
Correlation
The correlation between CURE.DE and DAVV.DE is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.43 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. DAVV.DE — Risk / Return Rank
CURE.DE
DAVV.DE
CURE.DE vs. DAVV.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and VanEck Crypto and Blockchain Innovators UCITS ETF (DAVV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | DAVV.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.52 | ||
| Sortino ratioReturn per unit of downside risk | -0.83 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.16 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.03 | -0.73 |
| Martin ratioReturn relative to average drawdown | 0.68 | 1.90 | -1.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | DAVV.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.81 | -0.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.02 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | -0.05 | -0.09 |
Drawdowns
CURE.DE vs. DAVV.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, smaller than the maximum DAVV.DE drawdown of -91.53%. Use the drawdown chart below to compare losses from any high point for CURE.DE and DAVV.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | DAVV.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -91.53% | +56.73% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -45.68% | +26.61% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -60.00% | +30.68% |
Max Drawdown (5Y)Largest decline over 5 years | — | -91.53% | — |
Current DrawdownCurrent decline from peak | -15.66% | -34.58% | +18.92% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -57.66% | +42.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 24.79% | -16.26% |
Volatility
CURE.DE vs. DAVV.DE - Volatility Comparison
The current volatility for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) is 5.73%, while VanEck Crypto and Blockchain Innovators UCITS ETF (DAVV.DE) has a volatility of 14.56%. This indicates that CURE.DE experiences smaller price fluctuations and is considered to be less risky than DAVV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | DAVV.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 14.56% | -8.83% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 40.57% | -25.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 58.12% | -38.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 70.78% | -50.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 70.57% | -49.83% |
CURE.DE vs. DAVV.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is lower than DAVV.DE's 0.65% expense ratio.
Dividends
CURE.DE vs. DAVV.DE - Dividend Comparison
Neither CURE.DE nor DAVV.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and DAVV.DE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CURE.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CURE.DE is cheaper with a 0.35% expense ratio, compared with 0.65% for DAVV.DE.
CURE.DE is categorized as Health & Biotech Equities, while DAVV.DE is Technology Equities. CURE.DE tracks MVIS Global Future Healthcare ESG, while DAVV.DE tracks MVIS Global Digital Assets Equity. Their fees differ too: 0.35% for CURE.DE and 0.65% for DAVV.DE.
Find the right allocation for CURE.DE and DAVV.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer